TOLREMO therapeutics ^None

TOLREMO therapeutics is a company that develops small molecules to target drug resistance pathways in cancer therapy. Their molecules can eradicate cancer cells that cause drug resistance, providing personalized anti-drug resistance therapies to prolong the lives of cancer patients. The company aims to prevent non-genetic cancer drug resistance by dismantling the earliest defense to targeted therapies, surmounting a universal challenge for current and future targeted therapies for lasting patient benefit.